Cargando…
Deep whole genome sequencing identifies recurrent genomic alterations in commonly used breast cancer cell lines and patient-derived xenograft models
BACKGROUND: Breast cancer cell lines (BCCLs) and patient-derived xenografts (PDXs) are the most frequently used models in breast cancer research. Despite their widespread usage, genome sequencing of these models is incomplete, with previous studies only focusing on targeted gene panels, whole exome...
Autores principales: | Deng, Niantao, Minoche, Andre, Harvey, Kate, Li, Meng, Winkler, Juliane, Goga, Andrei, Swarbrick, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509640/ https://www.ncbi.nlm.nih.gov/pubmed/36153537 http://dx.doi.org/10.1186/s13058-022-01540-0 |
Ejemplares similares
-
Evaluation of genomic high-throughput sequencing data generated on Illumina HiSeq and Genome Analyzer systems
por: Minoche, André E, et al.
Publicado: (2011) -
Whole-genome resequencing of common bean elite breeding lines
por: de Souza, Isabela Pavanelli, et al.
Publicado: (2023) -
Whole-Genome Sequencing as a First-Line Genetic Test in Familial Dilated Cardiomyopathy
por: Minoche, Andre E., et al.
Publicado: (2018) -
Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
por: Davis, Ryan L., et al.
Publicado: (2022) -
Cyclin E2 Promotes Whole Genome Doubling in Breast Cancer
por: Lee, Christine, et al.
Publicado: (2020)